ketotifen has been researched along with Atherogenesis in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atherosclerosis was produced in apolipoprotein E-deficient (Apoe(-/-)) mice with a Western diet." | 1.43 | Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice. ( Cheng, X; Fernandes, C; Huang, X; Levy, B; Liao, M; Libby, P; Liu, CL; Santos, MM; Shi, GP; Sukhova, GK; Wang, Y; Wu, G; Yang, C; Zhang, JY, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, CL | 1 |
| Wang, Y | 1 |
| Liao, M | 1 |
| Santos, MM | 1 |
| Fernandes, C | 1 |
| Sukhova, GK | 1 |
| Zhang, JY | 1 |
| Cheng, X | 1 |
| Yang, C | 1 |
| Huang, X | 1 |
| Levy, B | 1 |
| Libby, P | 1 |
| Wu, G | 1 |
| Shi, GP | 1 |
1 other study available for ketotifen and Atherogenesis
| Article | Year |
|---|---|
Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Budesonide; Chronic Disease; Disease Progression; Gluco | 2016 |